The results revealed that the increased UCP1 mRNA was significantly associated with improved overall survival of Stage 3 and Grade 3 ovarian cancer patients (p < 0.05) (Fig. 2A-B). This evidence concerns the gene UCP1 and ovarian carcinoma.